XTL BIOPHARMACEUTICALS LTD | CIK:0001023549 | 3

  • Filed: 3/15/2018
  • Entity registrant name: XTL BIOPHARMACEUTICALS LTD (CIK: 0001023549)
  • Generator: Ez-XBRL
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/0001213900-18-003028-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1023549/000121390018003028/xtlb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001023549
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory

    NOTE 19: FINANCE INCOME (EXPENSES), NET

     

        Year ended December 31,  
        2017     2016     2015  
        U.S. dollars in thousands  
    Finance expenses:                  
    Issuance cost related to warrants to investors     329       -       -  
    Bank account management fees and commissions     8       7       9  
    Other financial expenses     -       -       6  
                             
    Total finance expenses     337       7       15  
                             
    Finance income:                        
    Revaluation of warrants to purchase ADS’s     765       -       -  
    Interest income on bank deposits     16       -       -  
    Exchange differences     21       23       4  
                             
    Total finance income     802       23       4  
                             
    Finance income (expenses), net     465       16       (11 )